Related scientific articles (all)

Microvesicles and Cancer.

Authors : Azerad MA, Debaugnies F, Demulder A, Bron D, Efira A
Year : 2013
Journal : Belgian J Hematology
Volume : 4
Pages : 1

Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.

Authors : Oakman C, Francis PA, Crown J, Quinaux E, Buyse M, de Azambuja E, Margeli Vila M, Andersson M, Nordenskjöld B, Jakesz R, Thürlimann B, Gutiérrez J, Harvey V, Punzalan L, Dell orto P, Larsimont D, Steinberg I, Gelber Rd, Piccart-Gebhart M, Viale G, Di Leo A
Year : 2013
Journal : Ann Oncol
Volume : 24(5)
Pages : 1203-11

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial.

Authors : Azim HA, Agbor-Tarh D, Bradbury I, Dinh P, Baselga J, Di Cosimo S, Greger JG, Smith I, Jackisch C, Kim SB, Aktas B, Huang CS, Vuylsteke P, Hsieh RK, Dreosti L, Eidtmann H, Piccart-Gebhart M, de Azambuja E
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(36)
Pages : 4504-11

Stratified Medicine: a call for action

Authors : Awada A, Annemans L, Broeckx D, Pauwels P, Simoens S, Van Belle S, van Cutsem E, Van Hoof E, De Greve J
Year : 2013
Journal : Belgian J Medical Oncology
Volume : 7(1)
Pages : 15-19

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines but modulates genes that are involved in adaptation in vitro.

Authors : Dom G, Chico Galdo V, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelaer V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren W
Year : 2013
Journal : Thyroid
Volume : 23(3))
Pages : 317-28

The European lung corner.

Authors : Sculier JP
Year : 2013
Journal : Eur. Respir. J.
Volume : 42(6)
Pages : 1433-4

Targeting RANKL in breast cancer: bone metastasis and beyond.

Authors : Azim H, Azim HA
Year : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(2)
Pages : 195-201

Ibrutinib : a major breakthrough in the treatment of CLL and other lymphoproliferative disorders.

Authors : Bron D
Year : 2013
Journal : Belgian J Hematology
Volume : 4(3)
Pages : 102-105

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.

Authors : Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE, Piccart-Gebhart M
Year : 2013
Journal : Cancer Treat Rev
Volume : 39(8)
Pages : 935-46

High-risk human papillomavirus infection in HIV-positive African women living in Europe.

Authors : Konopnicki D, Manigart Y, Gilles C, Barlow P, De Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N
Year : 2013
Journal : J Int AIDS Soc
Volume : 16
Pages : 18023

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial.

Authors : Azim HA, Rothé F, Aura CM, Bavington M, Maetens M, Rouas G, Gebhart G, Gamez C, Eidtmann H, Baselga J, Piccart-Gebhart M, Ellis C, Vuylsteke P, Cure H, Domont J, Ferro A, Toral-Peña JC, de Azambuja E, Sotiriou C, Di Cosimo S, Ignatiadis M
Year : 2013
Journal : Breast
Volume : 22(6)
Pages : 1060-5

Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

Authors : Pritchard KI, Burris HA, Ito Y, Rugo HS, Dakhil S, Hortobagyi GN, Campone M, Csöszi T, Baselga J, Puttawibul P, Piccart-Gebhart M, Heng D, Noguchi S, Srimuninnimit V, Bourgeois H, Gonzalez Martin A, Osborne K, Panneerselvam A, Taran T, Sahmoud T, Gnant M
Year : 2013
Journal : Clin Breast Cancer
Volume : 13(6)
Pages : 421-432.e8

Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches.

Authors : De Kock J, Najar M, Bolleyn J, Al Battah F, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Year : 2012
Journal : ALTEX
Volume : 29
Pages : 31-9

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Authors : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Year : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610

Clinical trial design in head and neck cancer: from past experiences to future perspectives.

Authors : de Castro G Jr, Henrique dos Anjos C, Lalami Y, Awada A
Year : 2012
Journal : Clinical Investigation
Volume : 2(5)
Pages : 473-481

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

Euthanasia: from ethical debate to clinical reality.

Authors : Berghmans T, Lossignol D
Year : 2012
Journal : Eur. Respir. J.
Volume : 40(4)
Pages : 804-5

Communication skills training for residents : which variables predict learning of skills?

Authors : Bragard I, Merckaert I, Libert Y, Delvaux N, Etienne AM, Marchal S, Reynaert C, Razavi D
Year : 2012
Journal : Open Journal of Medical Psychology
Volume : 1
Pages : 68-75

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Authors : Ignatiadis M, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1653-5

Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Authors : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Year : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pages : 157-68